In general, antimicrobial catheters are impregnated either with antibiotics (single agent or a combination) or silver salts (e.g., silver sulfadiazine).
Although there have been several studies and randomized controlled trials (RCTs) that investigated the benefits of antimicrobial EVD catheters, 11, 22 there has not yet been a dedicated study comparing antimicrobial and conventional ELD catheters.
Furthermore, antimicrobial EVD catheters seem to be especially effective at preventing CSF infections with gram-positive bacteria.
2 However, there are only sparse preclinical data available on the antimicrobial effects of si-catheters 27 on different bacteria and fungi. As this is a pilot study, the primary outcome is the comparison between conventional ELDs and silver-impregnated ELDs (si-ELDs) with regard to usability and handling, as tested with a questionnaire.
Secondary outcomes are the rate of infections for each ELD system and the rate of complications (both being defined by a set of criteria) and post hoc testing of all isolated microorganisms for silver susceptibility.
Methods
The SiLuDrain Trial (originally named the Silver-Coated Lumbar Drainage Trial) was conducted and planned as a monocentric open-label prospective randomized controlled trial to compare handling and infection and complication rates of conventional and si-ELD systems. This trial was registered with the German Registry of Clinical Trials (Deutsches Register Klinischer Studien; www.drks. de) as DRKS00013513.
Patients
Adults with an indication for ELD placement were eligible to participate in the study as long as they had not undergone ELD placement during the previous 3 months and did not have preexisting or suspected meningitis/CSF infection, known silver allergy, or known or suspected leptomeningeal spread of tumor cells. Concomitant placement of an EVD was not regarded as grounds for exclusion.
After it was determined that a patient met the criteria for inclusion, the patient or his/her legal representative was given oral and written information on the SiLuDrain study, was offered the opportunity for study participation, and was asked to provide written informed consent.
Randomization
Treatment allocation was randomized on a 1:1 ratio in randomization blocks of 4 as determined by a preexisting list created by a randomizer. Study participants were given a consecutive study number. Consecutively numbered, identical sealed envelopes containing the allocated ELD placement kit, the questionnaire, and a study timeline to be added to the patients' charts were prepared by a study nurse otherwise not involved with patient recruitment of this study.
After written informed consent was obtained, participating physicians retrieved the consecutively numbered sealed envelopes. Treatment allocation was therefore revealed to the physicians and patients only immediately before ELD placement.
Sample Size
Based on retrospective data, the expected infection rate with ELDs was estimated to be 7%. Therefore, a trial adequately powered to show a reduction of 50% or more in CSF infections with si-ELDs would require more than 1000 patients to be included. In this pilot study, the enrollment period was limited to 1 year with an expected enrollment of 40 participants (20 in each study arm).
Lumbar Drain Kits
The standard lumbar drain kits used in the control group were Integra Ideaflow ELD (Integra) sets without any antimicrobial impregnation.
The silver-impregnated lumbar drain kits used in the study group were Spiegelberg Silverline ELD sets.
Both catheters had the same outer and inner diameters (1.6 mm and 0.8 mm, respectively) as well as a length of 80 cm. A 14-gauge Tuohy needle was used to perform a lumbar puncture for catheter insertion in both groups.
Using their respective connectors, the ELDs were connected to the Neuromedex VentrEX CSF collection system.
ELD Placement
Participating resident neurosurgeons (year 1-6) had received an introduction to this study prior to enrollment of the first patient. Only residents who were already trained in ELD placement participated.
ELDs were placed in a sterile fashion on the patient's ward. Perioperative antibiotic prophylaxis was not performed. In conscious patients, local anesthetics were administered. Lumbar puncture was performed in the L4-5 or L3-4 interlaminar space and a 20-to 30-cm length of the ELD catheter was inserted through the Tuohy needle into the intrathecal space. The patency of all systems was checked before removing the Tuohy cannula and connecting the catheter to the CSF collection system. The catheter was secured by draping it to the back and flank of the patient. The CSF collection system was adjusted in height according to the volume of CSF to be drained per hour (standard: 5-10 ml/hour).
ELD Assessment
After ELD placement the performing resident neurosurgeon rated the individual steps and the overall placement on an ordinal scale, awarding 1 to 5 points (1 = very bad, 2 = bad, 3 = moderate, 4 = good, 5 = very good), in a short questionnaire. Six items were rated: preparation of placement, lumbar puncture, inserting the catheter, fixation of the catheter, connection to the CSF collection system, and the overall rating of ELD placement.
ELD Management
Daily inspections of the puncture site were performed. CSF samples were obtained on the day of ELD placement and then every second day until removal. CSF samples were checked for white blood cell counts and concentrations of protein, glucose, and lactate. Furthermore, Gram staining and microbiological cultures were performed to check for infection. ELDs were removed upon the deci-sion of the treating staff neurosurgeon and based on clinical criteria (see below). At the time of removal, the catheter tip was sent in for testing for microbial colonization.
Definition of CSF Infection
A slightly modified definition of the CDC definition 10 for healthcare-associated meningitis/ventriculitis was used (Table 1) .
Indications for ELD Exchange
A CSF infection defined as shown in Table 1 was judged as an indication for ELD exchange. Mechanical complications (dislocation, catheter tearing, catheter blockage) were also considered indications for ELD exchange.
Patients with an indication for an ELD exchange were not allowed to cross over into the other study group. In case the patient was regarded as not needing further temporary lumbar CSF drainage, the drain could be removed without replacement. Complications with the ELD systems were also documented (catheter occlusion, catheter dislocation, disconnection from the CSF collection system, catheter placement impossible).
Antimicrobial Susceptibility Testing
All isolated microbial strains from catheter tips and CSF samples were subjected to routine microbiological diagnostics as well as silver susceptibility testing to evaluate their susceptibility or resistance to the antimicrobial properties of ELDs. The stored isolated strains were then analyzed for growth on silver-impregnated and conventional lumbar catheters as described previously. 27 Conventional and silver-impregnated catheters of 4 cm length were separately placed in the bacterial suspension and incubated for 3 hours and then another 21 hours at 37°C, and colonyforming units (CFUs) were counted at the end of both periods. 7 A reduction of CFUs at the 24-hour time point compared to the 3-hour time point was regarded as a sign of antimicrobial susceptibility to silver in the absence of a similar reduction for the conventional catheter.
Interpretation Criteria
According to criteria defined by Maki 18 for central venous catheters, an infection is suspected if 15 or more CFUs are grown after the catheter is rolled on an agar plate. Numbers of CFUs below 15 are regarded as evidence of contamination with skin flora.
As CSF is a sterile specimen, any detection of growth is regarded as relevant. However, due to manipulation of the system, contamination may occur when collecting the CSF. Therefore, results of microbiological cultures were interpreted with other signs of infection. Single cultivation in low amounts of bacteria from skin flora and without other signs of infection was regarded as indicating contamination.
Statistics
Statistics were calculated using SPSS version 23 (IBM Corp.). Descriptive statistics (statistical mean, median, range, and standard deviation) were used for demographic and clinical data (such as age, sex, indication for ELD, duration of ELD placement) from both study groups. To compare the study groups for statistical differences (such as in age, sex, or indication for ELD) the Student t-test was used. Differences in the numbers of CSF infections and the number of complications in the 2 groups were checked for statistical significant using the Pearson chi-square test. To compare the usability questionnaire scores for the 2 study groups and check for significant differences, the MannWhitney U-test was used. Statistical significance was defined as p < 0.05; confidence intervals were set at 95%.
Ethics
This study was performed in accordance with the current version of the Declaration of Helsinki for ethical principles for medical research involving human subjects. The guidelines for good clinical practice were followed while planning and executing this study. The study was approved by the ethics committee of the medical faculty of the University of Heidelberg.
Results

Patient Characteristics
During the enrollment period a total of 54 patients were deemed eligible for the SiLuDrain trial. Six eligible patients were not included in the study: 2 of these patients reported having had an allergic reaction to silver and the other 4 refused to participate in a randomized trial and did not give informed consent after oral and written information about the nature of the study was given to them (also see Fig. 1 ).
A total of 48 patients were enrolled in this study, with 24 randomized to the si-ELD group (study group) and 24 randomized to receive a conventional ELD (control group). This result exceeded our expected sample size by 20%. All patients could be included in the final analysis. The study groups did not differ significantly with respect to demographic or clinical characteristics ( Table 2) . The indications for ELD placement were posthemorrhagic (communicating) hydrocephalus, CSF fistulas, and diagnostic tests. The variation of indications did not differ significantly between the 2 groups (p value range 0.37-0.76, t-test).
CSF Infections
Catheter-associated CSF infections as defined previously were observed in 10.4% of cases. The number of catheter-associated CSF infections was lower in the study group (1, 4.2%) than in the control group (4, 16.7%), but the difference was not statistically significant (p = 0.16, chi-square test). Four of the 5 patients with CSF infections were female. In 4 cases the ELD was placed to treat posthemorrhagic hydrocephalus. One patient had received the ELD for treatment of a CSF fistula. None of the patients who underwent ELD placement for diagnostic tests developed a CSF infection.
CSF infections were diagnosed after a mean of 7.2 days (range 6-9 days) after ELD placement. The mean and median times that ELDs were placed for were exactly the same in both groups (mean 4.4 days, median 4.0 days, range 1-10 days).
In 3 of 5 patients, an EVD was in place at the time of ELD placement. In 3 patients, positive CSF cultures led to the diagnosis of CSF infection. Two more infections were determined by the combination of positive Gram stain and CSF pleocytosis or the combination of fever and colonization of the catheter tip. In all cases, different strains of staphylococci could be isolated either from CSF culture or 
ELD Complications
The rate of device-related complications with ELD systems was 18.8% (Table 3) . No severe complications (e.g., spinal epidural hematoma, nerve root injury, or intracranial hemorrhage) were detected. Only 2 complications occurred in the study group (8.3%), whereas 9 complications were detected in the control group (37.5%). This represents a significant difference in occurrence of devicerelated complications (p = 0.02, chi-square test).
ELD Usability
In all cases, ELD assessment questionnaires were available (Table 4 ). The si-ELD systems were overall rated significantly better than the conventional ones (p = 0.003, Mann-Whitney U-test). The ELD system from the study group had a higher median rating in each individual step of placing the ELD as well. Significant differences favoring si-ELD systems were detected for preparation of placement (p = 0.038), catheter insertion (p = 0.002), and catheter fixation (p = 0.024), but not for lumbar puncture (p = 0.116) or connection to the CSF collection system (p = 0.667).
Isolated Microorganisms and Antimicrobial Susceptibility Testing
Microorganisms were isolated from 14 CSF samples or catheter tips; in 13 instances, the infecting organism was bacterial and in 1 instance it was fungal (Table 5) . This includes the cases with proven CSF infection, cases with cultured microorganisms where contamination was assumed, and cases when catheters were removed as planned without the patient meeting criteria for catheterassociated CSF infection. Only 1 case of infection with gram-negative rods (Escherichia coli) occurred. All other isolated organisms were gram-positive cocci, with S. epidermidis being the most common organism.
The 3-hour results show confluent and dense growth for all microorganisms in the isolate solutions containing the conventional catheters and those containing the silverimpregnated catheters, proving successful cultivation.
After 24 hours some samples showed reduced growth with both the conventional and the silver-impregnated catheter, but comparison of the range of reduction showed that the silver-impregnated catheter was superior to the conventional one in 10 of 14 cases (71.4%). In 2 cases (one fungal and one gram-negative sample), neither of the solutions (i.e., the one containing the si-ELD or the one containing the conventional catheter) showed any reduction in growth. In 2 cases, the solution containing the silverimpregnated catheter showed less growth reduction compared to the conventional one. Interestingly these cases were 1 of the 4 cases of S. epidermidis and 1 of the 3 cases of S. haemolyticus.
Discussion
This study is-to our knowledge-the first RCT to investigate and compare conventional versus si-ELD catheters. Furthermore, this is also the first trial to document device-related complication rates for and elucidate the antimicrobial properties of silver-impregnated catheters.
As far as our rate of infection is concerned, 10.4% is toward the upper end of the range reported in the literature. 1, 14 This rate is higher than our own infection rate prior to this study (7%). This difference is most likely explained by the fact that, like others, we did not have defined and strict criteria on how to determine that a patient had an ELD-associated CSF infection in our regular clinical practice.
Definitions for a catheter-associated CSF infection differ among authors. 9, 10 In most publications dealing with catheter-associated CSF infections, only a positive culture of a microorganism from a CSF sample is regarded as definitive evidence of an infection.
Only very recently the Infectious Diseases Society of America (IDSA) published practice guidelines for "healthcare-associated ventriculitis and meningitis." These guidelines include all scenarios in which catheters are placed in the CSF space (EVDs, ELDs, ventriculoperitoneal shunts, and intrathecal pumps). Although there is no singular definition of a healthcare-associated CSF infection, the authors give a very nuanced guideline and recommendations of different strengths (weak, moderate, strong) with regard to clinical symptoms, findings in serum and CSF, and microbiological findings. All of the criteria that we utilized to define a CSF infection in this study are mentioned in this guideline, with CSF cultures being declared as the most important test to determine a CSF infection. In our study, positive CSF cultures occurred in only 60% of our cases rated as infections. In 2 more cases, the combination of clinical signs of meningitis and CSF changes or a positive Gram stain led to the clinical definition of a catheter-associated CSF infection.
As the number of overall publications regarding ELDs is much smaller than for EVDs, a dedicated rate of devicerelated complications was not available in the literature. Our detected rate of 18.8%, however, shows that patients with ELDs require special observation whether they are bedridden in an intensive care unit or mobile in a regular ward.
It should be noted that all infections in this study occurred in patients who either had intracranial surgery or had posthemorrhagic hydrocephalus. In only 1 of the 5 cases was ELD placement the first opening of the dura.
None of the patients with diagnostic indications for ELD placement (in most cases, suspected NPH) developed an infection. Not only did these patients not have another opening of the dural space before, but ELDs were usually placed for no longer than 72 hours, as this currently represents the method with the highest diagnostic value for NPH. 17 None of the infections in our study occurred prior to day 6. This is in accord with the findings of Liang et al., 14 who describe ELD placement for longer than 4 days to be a risk factor for infection in patients with after subarachnoid hemorrhage. We saw a significantly lower rate of complications with silver-impregnated catheters. Although both ELDs used in this study had the same length as well as the same inner and outer diameter and both were placed using a 14-gauge Tuohy needle, there are differences to be noted. The conventional catheter must be placed using a guidewire, whereas the silver-impregnated one is more rigid and can be placed without any additional aids. This fact may be reflected in the significantly better usability score given for the silver-impregnated catheter in the "catheter insertion" category, as well as the occurrence of 2 complications involving catheter insertion with the need for an additional lumbar puncture in the control group.
Another aspect leading to 2 complications was the connection to the CSF collection system. Silver-impregnated catheters were rated nonsignificantly better than conventional ones for this step. Tight and durable connections to the CSF collection system can prevent disconnection and the resulting contact of CSF with the patient's environment, which would pose a risk for infection. While the conventional ELD has a connector that is sutured on, the silver-impregnated one has a Luer lock-like system, which did not lead to any disconnection in our study.
It should be noted that in our study CSF samples were obtained every other day while the catheter was in place to get a better overview of changes in CSF pleocytosis and growth of microorganisms. As every manipulation of a CSF drainage system can be a potential risk for infection, this is not recommended anymore. 9 It is advised to only obtain CSF samples when there is strong clinical suspicion of CSF infection, which also has become common practice in our department. This and a catalog of other means have been shown to reduce the rate of infections associated with external CSF drains. 13 One controversial consideration is prophylactic anti- biotic treatment with external CSF drains. In our study, the choice was up to the neurosurgeon in charge. Two of our 5 infections occurred in patients who were at that time receiving antibiotic treatment for respiratory tract infections. Prophylactic antibiotic treatment when placing a CSF drain is no longer recommended. 9, 13 Whether it is advisable to give a single dose of an antibiotic prior to ELD placement as performed by Leverstein et al. and as recommended prior to EVD placement is currently unclear. 13 Regarding the results of meta-analyses on antimicrobial EVD catheter use, it seems reasonable to assume that antimicrobial catheters are superior to conventional ones in terms of infection rates. However, it is so far not clear whether silver impregnation conveys a stronger advantage than antibiotic impregnation. 2, 5, 26 To date, there are more studies published for catheters with antibiotic-impregnation and therefore the data may be interpreted as stronger. Nevertheless, a recent German survey among all major neurosurgical centers showed that si-EVDs are used more often compared to ones with antibiotic impregnation. Moreover, no dedicated ELD catheter with antibiotic impregnation is available on the market.
Testing silver-impregnated drains for growth reduction after inoculation with the isolated microorganisms showed that growth of gram-positive bacteria was especially inhibited. Out of 12 tested Staphylococcus isolates, the growth of 10 isolates was inhibited by the silver-impregnated drainage systems. Whether there is less activity against gram-negative organisms or fungi is not clear, as only one E. coli isolate and one Candida parapsilosis isolate was tested. Previous work by Zschaler reported growth reduction of 2 gram-negative reference strains, one E. coli and one Pseudomonas aeruginosa, as well as of 2 yeasts: C. glabrata and C. albicans. Therefore, it may be a strainspecific effect. However, the majority of catheter-related infections are caused by gram-positive bacteria, especially staphylococci, 2 and no single antibiotic-impregnated drain cannot prevent infection by all potential pathogens.
Our findings on the range of silver susceptibility and silver resistance of bacteria confirm but also exceed the known effects published earlier. 27 However, our results do not elucidate what kind of reduction of growth can clinically prevent a CSF infection, as multiple factors come into play.
The mechanism of action has not been fully determined. Silver ions bind to various structures of the cell and may thereby disturb cellular function and integrity. 4, 21 The antimicrobial activity of silver does not target a specific cellular structure, and therefore it is able to exert its effect on gram-positive and gram-negative bacteria as well as fungi. Nevertheless, resistance to silver has also been observed. 21, 23 It is interesting though, that in 2 cases single strains of S. epidermidis and S. haemolyticus did not show this effect. It is up for speculation whether genetic alterations or functional changes lead to resistance.
A correlation between the use of antibiotic-impregnated catheters and infection with methicillin-resistant S. aureus (MRSA) has been described. 12 Silver-impregnated drains may offer the benefit of a broad antimicrobial activity against gram-negative and gram-positive bacteria as well as fungi.
Silver compounds and conventional antibiotics may exert a synergistic effect. [19] [20] [21] Especially for the treatment of intraventricular infections, as some antibiotics, such as vancomycin and gentamycin, may be administered directly into the ventricle. 24 It is not known whether silver nanoparticles or compounds are shed from the catheter and may be dissolved in the CSF. This is the first study to provide combined information on patient characteristics, isolated microorganisms, and correlation with in vitro antimicrobial effect of the silverimpregnated drains on microbial isolates obtained from patients' CSF and/or catheter tips. Interestingly, one S. epidermidis isolate from one patient with infection in the study group was not inhibited by the silver-impregnated catheter in vitro. The other isolates from patients in the control group were inhibited by the silver-impregnated drains. One can speculate as to whether the use of si-ELDs would have prevented infection in these particular patients.
Our study does suffer from several limitations. First and foremost is the sample size. An adequately powered study would have required inclusion of more than 1000 patients, which would only be possible in the setting of a large multicenter trial, presumably with industry sponsorship. We can therefore not claim a significant reduction in catheter-associated infection with si-ELDs. Furthermore, patients with ELD placement for diagnostic tests may be neglected in a follow-up study, as it seems that catheter placement for less than 72 hours is not associated with a relevant risk of infection.
Although randomized and controlled, our study was conducted as an open trial. This is due to the fact that no manufacturer was able to supply us with both conventional and silver-impregnated catheters and a neutral packaging. In particular, the resident neurosurgeons who placed the ELDs were aware of the type of catheter they were using in each case. This might have induced a certain degree of bias with regard to the assessment of ELD usability. Still, our study provided some valuable information, as the first study to compare conventional and si-ELD catheters.
Conclusions
In our study, we showed a reduction in the number of catheter-associated CSF infections in patients who received si-ELDs compared with a control group treated with conventional ELDs, but we were unable to demonstrate statistical significance, presumably due to the small sample size. Usability of the si-ELDs was rated significantly better than that of the conventional ELDs, and significantly fewer complications occurred in the si-ELD group. Staphylococci were the most common microorganisms associated with CSF infections. Silver-impregnated catheters show in most cases a higher in vitro reduction of growth of grampositive bacteria. Patients with ELDs should be given close attention to further minimize the risk of infection or other device-related complications.
